Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-018911
Filing Date
2014-03-31
Accepted
2014-03-28 19:29:50
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v372242_10k.htm 10-K 1217479
2 EXHIBIT 31.1 v372242_ex31-1.htm EX-31.1 11543
3 EXHIBIT 31.2 v372242_ex31-2.htm EX-31.2 11555
4 EXHIBIT 32.1 v372242_ex32-1.htm EX-32.1 5284
  Complete submission text file 0001144204-14-018911.txt   10583893

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptbg-20131231.xml EX-101.INS 1996157
6 XBRL TAXONOMY EXTENSION SCHEMA ptbg-20131231.xsd EX-101.SCH 91031
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptbg-20131231_cal.xml EX-101.CAL 50959
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptbg-20131231_def.xml EX-101.DEF 428531
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptbg-20131231_lab.xml EX-101.LAB 536805
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptbg-20131231_pre.xml EX-101.PRE 495971
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51474 | Film No.: 14727385
SIC: 2834 Pharmaceutical Preparations